Qorvo is executing a recovery, with gross margins already at the FY2028 target of 47% and net debt set to vanish within a year. Learn why QRVO stock is a buy.
**TL;DR:** Doximity (DOCS) is a digital platform used by 80% of U.S. physicians for collaboration, telehealth, and medical news. They make money by charging pharma companies for targeted marketing access.…
Semiconductor strength led by Intel and Texas Instruments drove index-level gains, while weak guidance and capex concerns punished software and select industrial names.
An analysis of Apple's financials by JP Morgan suggests that Apple is heading into its earnings report with iPhone supply and demand imbalances largely settled, leaving margins and cost pressure as the issues that will decide the rest.